0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Dermatology | 
Notable Notes | 
Megan E. MacGillivray, MD(C)
JAMA Dermatol. 2015;151(2):143. doi:10.1001/jamadermatol.2014.3755.

JAMA Pediatrics | 
Editorial |  ONLINE FIRST
Ben J. Marais, PhD
JAMA Pediatr. Published online January 12, 2015. doi:10.1001/jamapediatrics.2014.3157

JAMA Pediatrics | 
Original Investigation |  ONLINE FIRST
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.
JAMA Pediatr. Published online January 12, 2015. doi:10.1001/jamapediatrics.2014.3158
Includes: Supplemental Content

JAMA | 
Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2014;312(24):2609. doi:10.1001/jama.2014.15967.

JAMA | 
Global Health | 
M. J. Friedrich
JAMA. 2014;312(23):2481. doi:10.1001/jama.2014.16703.

JAMA | 
Viewpoint | 
Thomas R. Frieden, MD, MPH; Karen F. Brudney, MD; Anthony D. Harries, MD, FRCP
JAMA. 2014;312(14):1393-1394. doi:10.1001/jama.2014.11450.

JAMA | 
JAMA Diagnostic Test Interpretation | 
Henry M. Blumberg, MD; Russell R. Kempker, MD, MSc
JAMA. 2014;312(14):1460-1461. doi:10.1001/jama.2014.4928.

JAMA Dermatology | 
Notable Notes | 
Filippo Pesapane, MD; Antonella Coggi, MD; Raffaele Gianotti, MD
JAMA Dermatol. 2014;150(9):969. doi:10.1001/jamadermatol.2014.559.

JAMA | 
Global Health | 
M. J. Friedrich
JAMA. 2014;312(7):687. doi:10.1001/jama.2014.10320.

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(5):477. doi:10.1001/jama.2014.9185.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Notable Notes  | 
The Multifarious Adirondack Chair
Megan E. MacGillivray, MD(C)
JAMA Pediatrics
Editorial  | 
Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents
Ben J. Marais, PhD
JAMA Pediatrics
Original Investigation  | 
Treatment for Preventing Tuberculosis in Children and Adolescents:  A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.
JAMA
Clinical Trials Update  | 
TB Regimens: Less Is Not More
Anita Slomski, MA